Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of antagonists of plasminogen activator inhibitor-1 (PAI-1) for the treatment of asthma and chronic obstructive pulmonary disease

Use of antagonists of plasminogen activator inhibitor-1 (PAI-1) for the treatment of asthma and chronic obstructive pulmonary disease

US Patent 6767540 · Granted Jul 27, 2004

Estimated economic value: $7,116,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Smoking substitute devices and associated methods, systems and apparatuses2025
Dispensing device and pharmaceutical composition for the treatment of rhinitis2025
Treatment of allergic rhinitis using a combination of mometasone and olopatadine2024
Skeleton representation of layouts for the development of lithographic masks2024
Dispensing device and pharmaceutical composition for the treatment of rhinitis2023
Treatment of allergic rhinitis using a combination of mometasone and olopatadine2022
Method, apparatus, and computer-readable medium for gathering information2021
Method, apparatus and computer-readable medium for aiding emergency response2021
Treatment of allergic rhinitis using a combination of mometasone and olopatadine2020
Treatment of allergic rhinitis using a combination of mometasone and olopatadine2020
Treatment of allergic rhinitis using a combination of mometasone and olopatadine2020
Treatment of allergic rhinitis using a combination of mometasone and olopatadine2020